Member Info for Timster

Abingdon and odx also had a little flurry today, maybe there is some consortium news in the offing. Clarification of which test the manufacturers will be churning out...

There was one today too

Don't worry mortgage is always the first to post the RNS no need to make a special effort. Strangely that seems the only time he posts.
Where is alwayswhining haha

Yep what an idiot...

Dont forget BAMS at 1000 tests a day, could also wipe out PCR

talking of shorts, @decorum hows yours :) :)

gone

seems momentous moment...

innova

Well its the most pointless test ever!

So I would have thought so their extra capacity from the mystery factory on the Wirral would come in handy....

and the yanks arent even here yet ;)

250 definitely going today

onwards, after lunch :)

to be fair there could be many 100'sk up I don't begrudge a bit of selling I'm in till the ex chi-nah valuation though ;)

--BAMS (Imminent)
This evaluation is expected to continue for another two or three weeks (from the 24th Feb update) and the Group is establishing outsourced manufacturing capacity for the BAMS tests in collaboration with Adeptrix so that it is in a position to formally validate the diagnostic product as soon as possible. Avacta is also in discussions with a large commercial partner to provide a route to market for the BAMS assay.

--- ISO accredited (end of March)
The Diagnostics Division has established a Quality Management System and the first external audit by the Group's Notified Body (BSI Group) was passed in December successfully. The second and final audit is scheduled for March 2021. A positive outcome of the second audit will lead to ISO13485 accreditation. This certification sets the organisational and operational framework for all current and future diagnostic product developments and it is an essential accreditation that underpins future commercial success.

---LFT CE MARK and SALES (End of March)
On the basis of these excellent initial data, the Group will now progress to a full clinical validation with a larger number of patient samples to CE mark the test for professional use, aiming to bring the test to market in Europe around the end of the first quarter of this year.

what about the Brazil variant though ;)

Looking very strong, all coming together for the MASSIVE reveal....

How decorums short is going :) :) :) :)

.

its a myth that if 1 share is bought its a sign to the market makers that an RNS is lodged and on the way.

.

the only £10bn contract I can see recently is this one:
https://bidstats.uk/tenders/2021/W06/744685624

but its an over arching NHS capacity contract